Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

ER Reactivation Therapy for Breast Cancer

NCT02188745

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
Locations
  • Baystate Medical Center Springfield, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

NCT01231347

Conditions
Adenocarcinoma of the Pancreas, Advanced Malignancy, Advanced Solid Tumors, +29 more
Locations
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 152 locations
View Trial Details
Completed

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

NCT04641871

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

NCT01326871

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +20 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UF Health Center at Orlando Health Orlando, Florida, United States
  • Martin Health System Stuart, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

NCT04193553

Conditions
Gastro Intestinal Stromal Tumour, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Centre Antoine LACASSAGNE Nice, Alpes-Maritimes, France
  • Hopital de La Timone Marseille, Bouches Du Rhône, France
  • Institut Paoli Calmette Marseille, Bouches-du-Rhône, France
  • Centre Georges-François Leclerc Dijon, Bourgogne-Franche-Comté, France
View all 14 locations
View Trial Details
Completed

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

NCT02049905

Conditions
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC Phoenix, Arizona, United States
  • The University of Arizona Tucson, Arizona, United States
  • City of Hope Medical Group Duarte, California, United States
View all 74 locations
View Trial Details
Completed

Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma

NCT01514188

Conditions
Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma, Neoplasm Metastasis, +8 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Stanford University Stanford, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Pennsylvania Hematology Oncology Associates Philadelphia, Pennsylvania, United States
View all 34 locations
View Trial Details

Related conditions